Thiopurine treatment. Significance of pharmacogenetic polymorphism
Schmiegelow, K.; Hertz, H.
Ugeskrift for Laeger 160(8): 1189-1191
1998
ISSN/ISBN: 0041-5782 PMID: 9492634 Document Number: 487312
Document emailed within 1 workday
Related Documents
Baslund, B.; Dalhoff, K.P.; Schmiegelow, K. 2005: Individual monitoring of thiopurine and methotrexate treatment Ugeskrift for Laeger 167(20): 2177-2179Sukhanov, V.A.; Piruzian, L.A. 2004: Pharmacogenetic challenges in the treatment of mental diseases Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 104(8): 83-86
Budzinskaia, M.V.; Pogoda, T.V.; Generozov, E.V.; Chikun, E.A.; Gurova, I.V.; Shchegoleva, I.V.; Sizova, M.V. 2013: Contemporary pharmacogenetic approaches to the treatment of age-related macular degeneration Vestnik Oftalmologii 129(5): 128-135
Balabolkin, I.I.; Bulgakova, V.A. 2016: Pharmacogenetic Markers of the Effectiveness of Treatment of Children with Atopic Bronchial Asthma Eksperimental'naia i Klinicheskaia Farmakologiia 79(11): 35-40
Lyzlova, S.N.; Stefanov, V.E.; Sotofatori, E. 1987: Polymorphism and creatine kinase activity. Diagnostic significance Vestnik Akademii Meditsinskikh Nauk SSSR 7: 29-34
Prins, J.; Leus, F.R.; van der Hoek, Y.Y.; Kastelein, J.J.; Bouma, B.N.; van Rijn, H.J. 1997: The identification and significance of a Thr-->Pro polymorphism in kringle IV type 8 of apolipoprotein(a) Thrombosis and Haemostasis 77(5): 949-954
Grzeszczak, W.; Zukowska-Szczechowska, E. 1998: The significance of candidate genes' polymorphism in the development of diabetic nephropathy Wiadomosci Lekarskie 51(Suppl 2): 11-23
Harada, S. 1990: Genetic polymorphism of aldehyde dehydrogenase and its physiological significance to alcohol metabolism Progress in Clinical and Biological Research 344: 289-294
Yao, J.; Wang, B.-J. 2014: Relationship between genetic polymorphism of dopamine receptor and schizophrenia and its forensic significance Fa Yi Xue Za Zhi 30(3): 202-206
Tarnow, L.; Parving, H.H.; Jacobsen, P.; Rossing, P.; Lecerf, L.; Poirier, O.; Cambien, F. 1998: The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors Ugeskrift for Laeger 160(34): 4886-4889
Watanabe, M.; Fukutome, K.; Murata, M.; Uemura, H.; Kubota, Y.; Kawamura, J.; Yatani, R. 1999: Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese Anticancer Research 19(5c): 4511-4514
Papadopoulou, E.; Anagnostopoulos, K.; Tripsianis, G.; Tentes, I.; Kakolyris, S.; Galazios, G.; Sivridis, E.; Simopoulos, K.; Kortsaris, A. 2008: Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism Neoplasma 55(3): 229-238
Laish, I.; Pomeranz, I.; Kitay-Cohen, Y.; Konikof, F. 2012: Thiopurine-induced hyperammonaemic encephalopathy in a patient with Crohn's disease Harefuah 151(12): 692
Lee, M.H.; Huang, Y.M.; Sartorelli, A.C. 1978: Alkaline phosphatase activities of 6-thiopurine-sensitive and -resistant sublines of Sarcoma 180 Cancer Research 38(8): 2413-2418
Dervieux, T.; Chu, Y.; Su, Y.; Pui, C.-H.; Evans, W.E.; Relling, M.V. 2002: HPLC determination of thiopurine nucleosides and nucleotides in vivo in lymphoblasts following mercaptopurine therapy Clinical Chemistry 48(1): 61-68
Woodson, L.C.; Dunnette, J.H.; Weinshilboum, R.M. 1982: Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies Journal of Pharmacology and Experimental Therapeutics 222(1): 174-181
Tani, C.; Mosca, M.; Colucci, R.; Gori, G.; d'Ascanio, A.; Ghisu, N.; Fornai, M.; Di Paolo, A.; Blandizzi, C.; Del Tacca, M.; Bombardieri, S. 2009: Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases Clinical and Experimental Rheumatology 27(2): 321-324
Woodson, L.C.; Ames, M.M.; Selassie, C.D.; Hansch, C.; Weinshilboum, R.M. 1983: Thiopurine methyltransferase. Aromatic thiol substrates and inhibition by benzoic acid derivatives Molecular Pharmacology 24(3): 471-478
Li, T.K.; McBride, W.J. 1995: Pharmacogenetic models of alcoholism Clinical Neuroscience 3(3): 182-188
Kostrzewska, E.; Gregor, A. 1986: Porphyria--a pharmacogenetic disease Wiadomosci Lekarskie 39(24): 1713-1717